IBDEI3FE ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,57630,1,3,0)
;;=3^Insomnia,Unspec
;;^UTILITY(U,$J,358.3,57630,1,4,0)
;;=4^G47.00
;;^UTILITY(U,$J,358.3,57630,2)
;;=^332924
;;^UTILITY(U,$J,358.3,57631,0)
;;=Z91.410^^267^2886^9
;;^UTILITY(U,$J,358.3,57631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57631,1,3,0)
;;=3^Personal Hx of Adult Physical & Sexual Abuse
;;^UTILITY(U,$J,358.3,57631,1,4,0)
;;=4^Z91.410
;;^UTILITY(U,$J,358.3,57631,2)
;;=^5063619
;;^UTILITY(U,$J,358.3,57632,0)
;;=B35.1^^267^2887^22
;;^UTILITY(U,$J,358.3,57632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57632,1,3,0)
;;=3^Tinea Unguium
;;^UTILITY(U,$J,358.3,57632,1,4,0)
;;=4^B35.1
;;^UTILITY(U,$J,358.3,57632,2)
;;=^119748
;;^UTILITY(U,$J,358.3,57633,0)
;;=L03.90^^267^2887^3
;;^UTILITY(U,$J,358.3,57633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57633,1,3,0)
;;=3^Cellulitis,Unspec
;;^UTILITY(U,$J,358.3,57633,1,4,0)
;;=4^L03.90
;;^UTILITY(U,$J,358.3,57633,2)
;;=^5009067
;;^UTILITY(U,$J,358.3,57634,0)
;;=L03.91^^267^2887^6
;;^UTILITY(U,$J,358.3,57634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57634,1,3,0)
;;=3^Lymphangitis,Acute,Unspec
;;^UTILITY(U,$J,358.3,57634,1,4,0)
;;=4^L03.91
;;^UTILITY(U,$J,358.3,57634,2)
;;=^5009068
;;^UTILITY(U,$J,358.3,57635,0)
;;=L25.9^^267^2887^4
;;^UTILITY(U,$J,358.3,57635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57635,1,3,0)
;;=3^Contact Dermatitis,Unspec Cause
;;^UTILITY(U,$J,358.3,57635,1,4,0)
;;=4^L25.9
;;^UTILITY(U,$J,358.3,57635,2)
;;=^5133647
;;^UTILITY(U,$J,358.3,57636,0)
;;=L40.0^^267^2887^17
;;^UTILITY(U,$J,358.3,57636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57636,1,3,0)
;;=3^Psoriasis Vulgaris
;;^UTILITY(U,$J,358.3,57636,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,57636,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,57637,0)
;;=L40.2^^267^2887^1
;;^UTILITY(U,$J,358.3,57637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57637,1,3,0)
;;=3^Acrodermatitis Continua
;;^UTILITY(U,$J,358.3,57637,1,4,0)
;;=4^L40.2
;;^UTILITY(U,$J,358.3,57637,2)
;;=^5009162
;;^UTILITY(U,$J,358.3,57638,0)
;;=L40.3^^267^2887^20
;;^UTILITY(U,$J,358.3,57638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57638,1,3,0)
;;=3^Pustulosis Palmaris et Plantaris
;;^UTILITY(U,$J,358.3,57638,1,4,0)
;;=4^L40.3
;;^UTILITY(U,$J,358.3,57638,2)
;;=^5009163
;;^UTILITY(U,$J,358.3,57639,0)
;;=L40.4^^267^2887^5
;;^UTILITY(U,$J,358.3,57639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57639,1,3,0)
;;=3^Guttate Psoriasis
;;^UTILITY(U,$J,358.3,57639,1,4,0)
;;=4^L40.4
;;^UTILITY(U,$J,358.3,57639,2)
;;=^5009164
;;^UTILITY(U,$J,358.3,57640,0)
;;=L40.8^^267^2887^18
;;^UTILITY(U,$J,358.3,57640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57640,1,3,0)
;;=3^Psoriasis,Other
;;^UTILITY(U,$J,358.3,57640,1,4,0)
;;=4^L40.8
;;^UTILITY(U,$J,358.3,57640,2)
;;=^271917
;;^UTILITY(U,$J,358.3,57641,0)
;;=L40.9^^267^2887^19
;;^UTILITY(U,$J,358.3,57641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57641,1,3,0)
;;=3^Psoriasis,Unspec
;;^UTILITY(U,$J,358.3,57641,1,4,0)
;;=4^L40.9
;;^UTILITY(U,$J,358.3,57641,2)
;;=^5009171
;;^UTILITY(U,$J,358.3,57642,0)
;;=L57.0^^267^2887^2
;;^UTILITY(U,$J,358.3,57642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57642,1,3,0)
;;=3^Actinic Keratosis
;;^UTILITY(U,$J,358.3,57642,1,4,0)
;;=4^L57.0
;;^UTILITY(U,$J,358.3,57642,2)
;;=^66900
;;^UTILITY(U,$J,358.3,57643,0)
;;=L97.911^^267^2887^16
;;^UTILITY(U,$J,358.3,57643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57643,1,3,0)
;;=3^Non-Prs Chr Ulc,Rt Low Leg,Limited to Brkdwn Skin
;;^UTILITY(U,$J,358.3,57643,1,4,0)
;;=4^L97.911
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3FE 3972 printed Nov 22, 2024@17:57:51 Page 2
IBDEI3FE ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,57630,1,3,0)
+2 ;;=3^Insomnia,Unspec
+3 ;;^UTILITY(U,$J,358.3,57630,1,4,0)
+4 ;;=4^G47.00
+5 ;;^UTILITY(U,$J,358.3,57630,2)
+6 ;;=^332924
+7 ;;^UTILITY(U,$J,358.3,57631,0)
+8 ;;=Z91.410^^267^2886^9
+9 ;;^UTILITY(U,$J,358.3,57631,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,57631,1,3,0)
+12 ;;=3^Personal Hx of Adult Physical & Sexual Abuse
+13 ;;^UTILITY(U,$J,358.3,57631,1,4,0)
+14 ;;=4^Z91.410
+15 ;;^UTILITY(U,$J,358.3,57631,2)
+16 ;;=^5063619
+17 ;;^UTILITY(U,$J,358.3,57632,0)
+18 ;;=B35.1^^267^2887^22
+19 ;;^UTILITY(U,$J,358.3,57632,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,57632,1,3,0)
+22 ;;=3^Tinea Unguium
+23 ;;^UTILITY(U,$J,358.3,57632,1,4,0)
+24 ;;=4^B35.1
+25 ;;^UTILITY(U,$J,358.3,57632,2)
+26 ;;=^119748
+27 ;;^UTILITY(U,$J,358.3,57633,0)
+28 ;;=L03.90^^267^2887^3
+29 ;;^UTILITY(U,$J,358.3,57633,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,57633,1,3,0)
+32 ;;=3^Cellulitis,Unspec
+33 ;;^UTILITY(U,$J,358.3,57633,1,4,0)
+34 ;;=4^L03.90
+35 ;;^UTILITY(U,$J,358.3,57633,2)
+36 ;;=^5009067
+37 ;;^UTILITY(U,$J,358.3,57634,0)
+38 ;;=L03.91^^267^2887^6
+39 ;;^UTILITY(U,$J,358.3,57634,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,57634,1,3,0)
+42 ;;=3^Lymphangitis,Acute,Unspec
+43 ;;^UTILITY(U,$J,358.3,57634,1,4,0)
+44 ;;=4^L03.91
+45 ;;^UTILITY(U,$J,358.3,57634,2)
+46 ;;=^5009068
+47 ;;^UTILITY(U,$J,358.3,57635,0)
+48 ;;=L25.9^^267^2887^4
+49 ;;^UTILITY(U,$J,358.3,57635,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,57635,1,3,0)
+52 ;;=3^Contact Dermatitis,Unspec Cause
+53 ;;^UTILITY(U,$J,358.3,57635,1,4,0)
+54 ;;=4^L25.9
+55 ;;^UTILITY(U,$J,358.3,57635,2)
+56 ;;=^5133647
+57 ;;^UTILITY(U,$J,358.3,57636,0)
+58 ;;=L40.0^^267^2887^17
+59 ;;^UTILITY(U,$J,358.3,57636,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,57636,1,3,0)
+62 ;;=3^Psoriasis Vulgaris
+63 ;;^UTILITY(U,$J,358.3,57636,1,4,0)
+64 ;;=4^L40.0
+65 ;;^UTILITY(U,$J,358.3,57636,2)
+66 ;;=^5009160
+67 ;;^UTILITY(U,$J,358.3,57637,0)
+68 ;;=L40.2^^267^2887^1
+69 ;;^UTILITY(U,$J,358.3,57637,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,57637,1,3,0)
+72 ;;=3^Acrodermatitis Continua
+73 ;;^UTILITY(U,$J,358.3,57637,1,4,0)
+74 ;;=4^L40.2
+75 ;;^UTILITY(U,$J,358.3,57637,2)
+76 ;;=^5009162
+77 ;;^UTILITY(U,$J,358.3,57638,0)
+78 ;;=L40.3^^267^2887^20
+79 ;;^UTILITY(U,$J,358.3,57638,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,57638,1,3,0)
+82 ;;=3^Pustulosis Palmaris et Plantaris
+83 ;;^UTILITY(U,$J,358.3,57638,1,4,0)
+84 ;;=4^L40.3
+85 ;;^UTILITY(U,$J,358.3,57638,2)
+86 ;;=^5009163
+87 ;;^UTILITY(U,$J,358.3,57639,0)
+88 ;;=L40.4^^267^2887^5
+89 ;;^UTILITY(U,$J,358.3,57639,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,57639,1,3,0)
+92 ;;=3^Guttate Psoriasis
+93 ;;^UTILITY(U,$J,358.3,57639,1,4,0)
+94 ;;=4^L40.4
+95 ;;^UTILITY(U,$J,358.3,57639,2)
+96 ;;=^5009164
+97 ;;^UTILITY(U,$J,358.3,57640,0)
+98 ;;=L40.8^^267^2887^18
+99 ;;^UTILITY(U,$J,358.3,57640,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,57640,1,3,0)
+102 ;;=3^Psoriasis,Other
+103 ;;^UTILITY(U,$J,358.3,57640,1,4,0)
+104 ;;=4^L40.8
+105 ;;^UTILITY(U,$J,358.3,57640,2)
+106 ;;=^271917
+107 ;;^UTILITY(U,$J,358.3,57641,0)
+108 ;;=L40.9^^267^2887^19
+109 ;;^UTILITY(U,$J,358.3,57641,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,57641,1,3,0)
+112 ;;=3^Psoriasis,Unspec
+113 ;;^UTILITY(U,$J,358.3,57641,1,4,0)
+114 ;;=4^L40.9
+115 ;;^UTILITY(U,$J,358.3,57641,2)
+116 ;;=^5009171
+117 ;;^UTILITY(U,$J,358.3,57642,0)
+118 ;;=L57.0^^267^2887^2
+119 ;;^UTILITY(U,$J,358.3,57642,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,57642,1,3,0)
+122 ;;=3^Actinic Keratosis
+123 ;;^UTILITY(U,$J,358.3,57642,1,4,0)
+124 ;;=4^L57.0
+125 ;;^UTILITY(U,$J,358.3,57642,2)
+126 ;;=^66900
+127 ;;^UTILITY(U,$J,358.3,57643,0)
+128 ;;=L97.911^^267^2887^16
+129 ;;^UTILITY(U,$J,358.3,57643,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,57643,1,3,0)
+132 ;;=3^Non-Prs Chr Ulc,Rt Low Leg,Limited to Brkdwn Skin
+133 ;;^UTILITY(U,$J,358.3,57643,1,4,0)
+134 ;;=4^L97.911
